Maltin Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-28,912
Closed -$959K 122
2023
Q3
$959K Buy
28,912
+1,355
+5% +$47.9K 0.67% 53
2023
Q2
$1.01M Sell
27,557
-396
-1% -$15.4K 0.71% 48
2023
Q1
$1.14M Sell
27,953
-154
-0.5% -$6.65K 0.82% 41
2022
Q4
$1.44M Sell
28,107
-546
-2% -$26.2K 1.05% 34
2022
Q3
$1.25M Sell
28,653
-632
-2% -$30.7K 0.99% 35
2022
Q2
$1.53M Buy
29,285
+163
+0.6% +$8.31K 1.11% 33
2022
Q1
$1.51M Buy
29,122
+2,028
+7% +$105K 1% 36
2021
Q4
$1.6M Buy
27,094
+73
+0.3% +$3.62K 0.96% 36
2021
Q3
$1.16M Buy
27,021
+153
+0.6% +$6.78K 0.71% 41
2021
Q2
$1.05M Buy
26,868
+3,245
+14% +$126K 0.64% 43
2021
Q1
$856K Buy
23,623
+8,689
+58% +$309K 0.56% 48
2020
Q4
$550K Sell
14,934
-13,991
-48% -$513K 0.39% 59
2020
Q3
$1.01M Buy
+28,925
New +$1.01M 0.72% 40
2020
Q1
Sell
-7,874
Closed -$293K 111
2019
Q4
$293K Buy
+7,874
New +$280K 0.19% 58

Other funds holding PFE